quinacrine has been researched along with Lung Adenocarcinoma in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Quinacrine has been used for therapeutic drugs in some clinical settings." | 5.46 | Quinacrine Inhibits ICAM-1 Transcription by Blocking DNA Binding of the NF-κB Subunit p65 and Sensitizes Human Lung Adenocarcinoma A549 Cells to TNF-α and the Fas Ligand. ( Harada, M; Hiramatsu, R; Kataoka, T; Kondo, T; Matsuda, I; Morimoto, K; Muko, R; Okina, Y, 2017) |
| "Quinacrine has been used for therapeutic drugs in some clinical settings." | 1.46 | Quinacrine Inhibits ICAM-1 Transcription by Blocking DNA Binding of the NF-κB Subunit p65 and Sensitizes Human Lung Adenocarcinoma A549 Cells to TNF-α and the Fas Ligand. ( Harada, M; Hiramatsu, R; Kataoka, T; Kondo, T; Matsuda, I; Morimoto, K; Muko, R; Okina, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, M | 1 |
| Morimoto, K | 1 |
| Kondo, T | 1 |
| Hiramatsu, R | 1 |
| Okina, Y | 1 |
| Muko, R | 1 |
| Matsuda, I | 1 |
| Kataoka, T | 1 |
1 other study available for quinacrine and Lung Adenocarcinoma
| Article | Year |
|---|---|
Quinacrine Inhibits ICAM-1 Transcription by Blocking DNA Binding of the NF-κB Subunit p65 and Sensitizes Human Lung Adenocarcinoma A549 Cells to TNF-α and the Fas Ligand.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Cell Proliferation; Cell | 2017 |